Global Electric Stimulation Devices Market: Industry Analysis, Market Dynamics & Forecast By 2026

DataM Intelligence announces its research report titled “Global Electric Stimulation Devices Market – Size, Share and Forecasts (2019-2026)” which reflects the size, share, forecast analysis of key players. The report worldwide analyses market drivers and restraints to provide market opportunities.
Global Electric Stimulation Devices Market Dynamics
In November 2017, Innovative Health Solutions, Inc., have received the U.S. Food and Drug Administration approval for a new indication to an electric stimulation device for use in helping to reduce the symptoms of opioid withdrawal. The NSS-2 Bridge device is a small electrical nerve stimulator placed behind the patient’s ear. It contains a battery-powered chip that emits electrical pulses to stimulate branches of certain cranial nerves.
In April 2017, electroCore has received the Food and Drug Administration approval for a device to treat cluster headaches, a rare form of headache that affects mostly men. GammaCore transmits a mild electrical stimulation to the vagus nerve through the skin, resulting in a reduction of pain.
Free | Get a copy of the sample report - https://www.datamintelligence.com/research-report/electric-stimulation-devices-market
Global Electric Stimulation Devices Segmentation
In August 2018, Abbott has received the U.S. Food and Drug Administration (FDA) approval for Infinity DBS system. Infinity Deep Brain Stimulation (DBS) System designed to treat patients with Parkinson’s disease and essential tremor. Moreover, in May 2018, Medtronic plc has received the U.S. Food and Drug Administration (FDA) premarket approval for Medtronic's Deep Brain Stimulation (DBS). DBS therapy for epilepsy delivers controlled electrical pulses to a target in the brain called the anterior nucleus of the thalamus (ANT), which is part of a network involved in seizures. Additionally, in December 2017, Boston Scientific Corporation has received the U.S. Food and Drug Administration (FDA) approval for the Vercise Deep Brain Stimulation (DBS) System. DBS is used to treat the symptoms of Parkinson's disease (PD), DBS works by stimulating a targeted region of the brain through implanted leads that are powered by a device called an implantable pulse generator (IPG).
In September 2017, Medtronic plc, have received FDA approval and U.S. launch of the Intellis platform for the management of certain types of chronic intractable pain. The Intellis platform is the next generation spinal cord stimulator for chronic pain.
Global Electric Stimulation Devices Regional Analysis
The global electric stimulation devices market is segmented into North America, Europe, Asia Pacific, South America and the Middle East and Africa.
North America is dominating the global electric stimulation devices market, due to the regulatory approval for electric stimulation devices, which is fueling the market growth. For instance, in January 2018, Nevro Corp. has received FDA approval for its next-generation Senza II Spinal Cord Stimulation (SCS) System delivering HF10 therapy. The Senza II system offers the superior outcomes and clinical advantages of HF10 therapy through a smaller and more refined footprint while maintaining the performance and durability of the current Implantable Pulse Generator (IPG). The launch of the new electric stimulation device is boosting the global electrical stimulation devices market.
Europe is showing significant growth in 2018, due to the regulatory approval for the electric stimulation devices. For instance, in November 2018, E-Motion Medical has received CE Mark approval for its E-Motion stimulation therapy system intended to treat patients with acute gastrointestinal dysmotility. E-Motion system is designed to deliver electrical stimulation to the oesophagus using its E-Motion tube.
Global Electric Stimulation Devices Company Trends
In January 2019, NeuroMetrix Inc., have introduced Quell 2.0, which is 50% smaller, yet 20% more powerful than its predecessor. It also takes pain relief technology and the first wearable technology to utilize machine learning to deliver unprecedented personalization for the treatment of chronic pain.
In September 2018, Nevro Corp. has received TGA approval for its next-generation Senza II Spinal Cord Stimulation (SCS) System delivering HF10 therapy. The Senza II system offers the superior outcomes and clinical advantages of HF10 therapy through a smaller and more refined footprint while maintaining the performance, durability, and full-body magnetic resonance imaging (MRI) conditional labelling of the current Implantable Pulse Generator (IPG).
The major players include Boston Scientific Corporation, Cyberonics, Inc, Colfax Corporation, Medtronic plc, Nevro Corporation, Abbott, NeuroMetrix, Inc., BTL Industries, Inc., Cogentix Medical Inc., and Zynex Inc.

Read more information about Global Electric Stimulation Devices Market - https://www.datamintelligence.com/research-report/electric-stimulation-devices-market

This report consists of the following table of contents -
1. Global Electric Stimulation Devices Market Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Global Electric Stimulation Devices Market – Market Definition and Overview
3. Global Electric Stimulation Devices Market – Executive Summary
3.1. Market Snippet by Device Type
3.2. Market Snippet by Application
3.3. Market Snippet by End User
3.4. Market Snippet by Region
3.5. DataM CLO Scenario
4. Global Electric Stimulation Devices Market – Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing regulatory approval for Electric Stimulation Devices
4.1.1.2. Increasing musculoskeletal disorders
4.1.2. Restraints
4.1.2.1. Stringent regulatory policies & safety concerns
4.1.2.2. Availability of cost-efficient alternative therapies
4.1.3. Opportunity
4.1.3.1. Increasing Pipeline products
4.1.4. Impact Analysis
5. Global Electric Stimulation Devices Market – Industry Analysis
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
5.4. Epidemiology
6. Global Electric Stimulation Devices Market – By Device Type
6.1. Introduction
6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type Segment
6.1.2. Market Attractiveness Index, By Device Type Segment
6.2. Spinal Cord Stimulation Devices
6.2.1. Introduction
6.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
6.3. Deep Brain Stimulation Devices
6.4. Vagus Nerve Stimulation Devices
6.5. Sacral Nerve Stimulation Devices
6.6. Gastric Electric Stimulation Devices
6.7. Transcutaneous Electrical Nerve Stimulation Devices
6.8. Neuromuscular Electrical Stimulation Devices
6.9. Cranial Electrical Stimulation Devices
6.10. Others
7. Global Electric Stimulation Devices Market – By Application
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Pain Management
7.2.1. Introduction
7.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026
7.3. Neurological and Movement Disorder Management
7.4. Musculoskeletal Disorder Management
7.5. Metabolism & GIT Management
7.6. Incontinence Management
7.7. Others
8. Global Electric Stimulation Devices Market – By End User
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
8.1.2. Market Attractiveness Index, By End User Segment
8.2. Hospital
8.2.1. Introduction
8.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
8.3. Specialty Clinics
8.4. Neurosurgical Centers
8.5. Ambulatory Surgical Centers
8.6. Others
9. Global Electric Stimulation Devices Market – By Region
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
9.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.2.6.1. U.S.
9.2.6.2. Canada
9.2.6.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
9.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.3.6.1. Germany
9.3.6.2. U.K.
9.3.6.3. France
9.3.6.4. Italy
9.3.6.5. Spain
9.3.6.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.4.6.1. Brazil
9.4.6.2. Argentina
9.4.6.3. Rest of South America
9.5. Asia Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.5.6.1. China
9.5.6.2. India
9.5.6.3. Japan
9.5.6.4. Australia
9.5.6.5. Rest of Asia Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10. Global Market – Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. Boston Scientific Corporation *
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Key Highlights
11.1.4. Financial Overview
11.2. Cyberonics, Inc
11.3. Colfax Corporation (DJO Global, Inc. acquired on November 2018)
11.4. Medtronic plc
11.5. Nevro Corporation
11.6. Abbott
11.7. NeuroMetrix, Inc.
11.8. BTL Industries, Inc.
11.9. Cogentix Medical Inc.
11.10. Zynex Inc.
11.11. Others
12. Global Electric Stimulation Devices Market – Premium Insights
13. Global Electric Stimulation Devices Market – DataM
13.1. Appendix
13.2. About Us and Services
13.3. Contact Us

About DataM Intelligence
DataM Intelligence 4Market Research is a Market Intelligence and Business Research firm, based in India. It aims to bridge the two main aspects of a business decision - opinion and supportive data.

Market Research for long has been losing its credibility owing to low reliability and high proportions of estimations. Having identified this gap, DataM was established to provide businesses with reliable and near-market intelligence. Reporting the actual market scenario has been made possible by our proprietary methodology, that essentially revolves around gathering inputs from industry participants and integrating the trends into statistical Databank. This approach not only aligns the findings with historical data but also allows a highly justifiable forecast model.

Corporate Address
1st floor, Phoenix Tech Tower, Plot no: 14/46, Habsidguda, IDA-Uppal, Hyderabad-500039, Telangana

Email
info@datamintelligence.com

Phone
+1 877-441-4866

This release was published on openPR.